Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022

dc.contributor.authorLucia Inchauste
dc.contributor.authorElif Nurtop
dc.contributor.authorLissete Bautista Machicado
dc.contributor.authorYanine Leigue Roth
dc.contributor.authorShirley Lenz Gonzales
dc.contributor.authorMaria Luisa Herrera
dc.contributor.authorKatty Mina Villafan
dc.contributor.authorPedro Mamani Mamani
dc.contributor.authorMarcelo Ramos Espinoza
dc.contributor.authorJuan Carlos Pavel Suarez
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:13:54Z
dc.date.available2026-03-22T19:13:54Z
dc.date.issued2024
dc.description.abstractThis study was supported by the French National Research Institute for Sustainable Development (IRD), the project EMERGEN-PRI #22275 of the ANRS I MIE (INSERM), and the European Union's Horizon 2020 research and innovation program (European Virus Archive Global, grant agreement No. 871029). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
dc.identifier.doi10.7554/elife.94475
dc.identifier.urihttps://doi.org/10.7554/elife.94475
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/74829
dc.language.isoen
dc.publishereLife Sciences Publications Ltd
dc.relation.ispartofeLife
dc.sourceInserm
dc.subjectSerology
dc.subjectSeroprevalence
dc.subjectVirology
dc.subjectNeutralization
dc.subjectPopulation
dc.subjectPandemic
dc.subjectAntibody
dc.subjectVirus
dc.subjectBiology
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.titleImproving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
dc.typearticle

Files